Health minister Andrew Little says the days of Pharmac prioritising the cheapest drugs possible over other considerations when making funding decisions are over
Pharmac has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, hormone replacement and HIV
Pharmac has announced today that it will be funding the preventative treatment, palivizumab, for the next two seasons of respiratory syncytial virus (RSV) for young children with severe diseases who need to be ventilated and pēpi (babies) with a high susceptibility for RSV-related illness and complications
The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected medicines with substantial clinical benefit is a welcome way of drawing attention to the plight of NZ cancer patients desperate for treatments that are funded across the Tasman, but not here, says Myeloma NZ Chief Executive Dr Ken Romeril
Pharmac is widening access to the antivirals to treat people with early COVID-19, after receiving feedback from our expert advisors and clinicians that the access criteria needed updating and to be streamlined
An equity-focused Pharmac report on the prevalence of gout within Pacific communities is a welcome first step, says south Auckland specialist GP and chair of the Pasifika GP Network Api Talemaitoga
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management